We are reprogramming immune cells to target the most challenging autoimmune diseases and cancer
Leadership
Gregory Frost, Ph.D.
Chairman & Chief Executive Officer
Stanley Frankel, M.D., F.A.C.P.
Chief Medical Officer
Gregory Wade, Ph.D.
Chief Business Officer & Head of Finance
Gregory Schreiber, Ph.D.
Vice President, Intellectual Property & Licensing
Richard Yan, C.P.A.
Vice President of Finance & Controller
Michelle Andraza
Vice President, Technical Operations
Lazaro Rodriguez
Vice President, IT and Connectivity
Joshua Shi, Ph.D.
General Manager, Shenzhen EXUMA Biotech
Board of Directors
Gregory Frost, Ph.D.
Chairman & Chief Executive Officer
Frank McCormick, Ph.D., F.R.S.
David Ramsay, M.B.A.
Daniel L. Flynn, Ph.D.
Houston Holmes, M.D., M.B.A., F.A.C.P
Scientific Advisory Board
Lawrence Steinman, MD
